Naloxone Take Home program prompts shortage

Next major import of drug not due until mid-November Just six weeks after the launch of the national Take Home Naloxone program there is already a significant shortage of the intranasal version of the opioid overdose resuscitation drug, with the TGA saying existing stocks are for “emergency supply only”. A recently published TGA shortage notice